Skip to content
★ Sign in to follow
PF

Paul F. Jacobson

Executive
Chairman & CEO
Thorne Healthtech, Inc.Progenics Pharmaceuticals Inc
Total declarations
26
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€552k

Latest filing published 18 Oct 2023 for Thorne Healthtech, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Paul F. Jacobson: trading record in brief

Paul F. Jacobson (chief executive) discloses dealings in 2 companies, chiefly Thorne Healthtech, Inc. and Progenics Pharmaceuticals Inc. We count 26 filings; the first trade dates from 15 July 2008 and the latest from 16 October 2023.

On the market, this insider has only sold: 6 sales, €552k in total. Outside the open market, there are 8 share grants and 5 option exercises.

On 18 October 2023 came the latest disclosure, a transaction in Thorne Healthtech, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Paul F. Jacobson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total

23 of 23 declarations